3 Cases of Erythrodermic Psoriasis with Korean Medical Treatment |
Yang, Ji-Eun
(Gangnam Dongyak Korean Medical Clinic)
Lee, Ki-Hoon (Gangnam Dongyak Korean Medical Clinic) Chang, Gyu-Tae (Department of Pediatrics. College of Korean Medicine, Kyung-Hee University) Yang, In-Jun (Department of Physiology. College of Korean Medicine, Dong-Guk University) |
1 | Kim MH, Lee BC, Yun YH, Choi IH. A Case of Psoriasis aggravated to Erythrodermic Psoriasis after Stopping Topical Steroids treated with Traditional Korean Medicine. J Korean Med Ophthalmol Otolaryngol Dermatol. 2012;25(1):104-11. DOI |
2 | Rosenbach M, Hsu S, Korman NJ, Lebwohl MG, Young M, Bebo BJ, et al. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;62(4):655-62. DOI |
3 | Park YH, Cheong SH, Lee JS, Kim SS, Shin HD. A Literatual Study of Psoriasis. The journal of K.O.M.S. 1988;9(1):131-6. |
4 | Kim NK, Hwang CY, Lim GS. The Oriental and Occidental bibliographic Study of Psoriasis. J Korean Med Ophthalmol Otolaryngol Dermatol. 1999;12(1):171-2. |
5 | Lyeom YH, Kim JE. Bokjinui Cheobanggwa Silche. 1st ed. Gangwon:Euibang Publishing Co. 2007:657-9. |
6 | Seo HS. The Experimental Study on Anti-inflammation and Anti-oxidation of Indigo Naturalis and Rehmanniae Radix. J Korean Med Ophthalmol Otolaryngol Dermatol. 2008;21(3):104-10. |
7 | Rho HS, Park YK, Bae HS. Effects of Tribuli Fructus Extract on Inflammatory Responses in IgE-stimulated RBL-2H3 mast cells. Korean Journal of Herbology. 2017;32(2):107-14. |
8 | Lyu JA, Jeong CH. Constitution of Prescription and Medicinal Effect & Adaptation Diseases of Bullsoosan in Korean Medical Books. J. Korean Medical Classics. 2016;29(1):17-41. |
9 | Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica. 1978;157(4):238-44. DOI |
10 | Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia. Arch InternMed. 2004;164(17):1888-96. |
11 | Korean Dermatology Association. Dermatology. 5th ed. Seoul:Ryo Moon Gak Publishing Co. 2008:241. |
12 | Weng HJ, Wang TS, Tsai TF. Clinical experience of secukinumab in the treatment of erythrodermic psoriasis: a case series. British Journal of Dermatology. 2018;178(6):1439-40. DOI |
13 | Rosenbach M, Hsu S, Korman NJ, Lebwohl MG, Young M, Bebo BF Jr, Van Voorhees AS. Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010;62(4):655-62. DOI |
14 | Roth PE, Grosshans E, Bergoend H. Psoriasis : development and fatal complications. Ann Dermatol Venereol. 1991;118(2):97-105. |
15 | Boyd AS, Menter A. Erythrodermic psoriasis : precipitating factors, course, and prognosis in 50 patients. J Am Acad Dermatol. 1989;21(5):985-91. DOI |
16 | Dika E, Bardazzi F, Balestri R, Maibach H. Environmental factors and psoriasis. Curr Probl Dermatol. 2007;35:118-35. |
17 | Fry L, Baker BS. Triggering psoriasis : The role of infections and medications. Clin Dermatol. 2007;25(6):606-15. DOI |
18 | Naldi L, Gambini D. The clinical spectrum of psoriasis. Clin Dermatol. 2007;25(6):510-8. DOI |
19 | Tracey EH, Elston C, Feasel P, Piliang M, Michael M, Vij A. Erythrodermic presentation of psoriasis in a patient treated with dupilumab. JAAD Case Rep. 2018;4(7):708-10. DOI |
20 | Yu SM, Son BK, Yun YH, Choi IH. A Case of Erythrodermic Psoriasis. J Korean Oriental Med. 2010;31(5):179-87. |
21 | Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's Dermatology in General Medicine. 6th ed. New York:McGraw-Hill. 2003:407-27. |